North Brunswick, NJ, United States of America

Madhava Reddy Uppugalla

This inventor holds 1 USPTO granted patent. Top assignee: Invamed, Inc.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Madhava Reddy Uppugalla. Retrieved from https://idiyas.com/inventor/madhava-reddy-uppugalla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Madhava Reddy Uppugalla: Innovator in Pharmaceutical Composition

Introduction

Madhava Reddy Uppugalla is a notable inventor based in North Brunswick, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly with his innovative compositions.

Latest Patents

Uppugalla holds a patent for a stabilized composition of ticlopidine hydrochloride. This novel pharmaceutical composition includes thieno-pyridine derivatives, primarily ticlopidine hydrochloride, without any other organic or inorganic acid stabilizing agents or metal stearates. The stable pharmaceutical composition also incorporates hydrogenated vegetable oil as a lubricant and other suitable non-ionic inert pharmaceutical excipients.

Career Highlights

Madhava Reddy Uppugalla is currently employed at Invamed, Inc., where he continues to work on advancements in pharmaceutical formulations. His expertise in this area has led to the development of innovative solutions that enhance the stability and efficacy of pharmaceutical products.

Collaborations

Uppugalla collaborates with Mukteeshwar Gande, contributing to the innovative environment at Invamed, Inc. Their teamwork fosters the development of cutting-edge pharmaceutical technologies.

Conclusion

Madhava Reddy Uppugalla is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact the industry significantly. His innovative approach and dedication to research exemplify the spirit of invention in the pharmaceutical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…